Genpharmasec Stock Screener | Share Price & Fundamental Analysis
GENPHARMA
Trading & Distributors
Screen Genpharmasec share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹1.35
▲
0.01 (0.75%)
Market Cap
₹75.82 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
1.10
EPS (TTM)
₹0.02
Dividend Yield
-
Debt to Equity
0.07
52W High
₹3.41
52W Low
₹1.29
Operating Margin
-1.00%
Profit Margin
-3.03%
Revenue (TTM)
₹33.00
EBITDA
-
Net Income
₹-1.00
Total Assets
₹80.00
Total Equity
₹65.00
Genpharmasec Share Price History - Stock Screener Chart
Screen GENPHARMA historical share price movements with interactive charts. Analyze price trends and patterns.
Genpharmasec Company Profile - Fundamental Screener
Screen Genpharmasec company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for GENPHARMA shares.
Sector
Commercial Services
Industry
Trading & Distributors
Sub-Sector
Trading & Distributors
Segment
E
ISIN
INE861N01036
Genpharmasec Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen GENPHARMA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 |
|---|---|---|---|
| Assets | |||
| Total Assets | 80 | 71 | 20 |
| Current Assets | 27 | 41 | 19 |
| Fixed Assets | 8 | 1 | 0 |
| Liabilities | |||
| Total Liabilities | 80 | 71 | 20 |
| Current Liabilities | 5 | 4 | 3 |
| Non-Current Liabilities | 0 | 0 | 0 |
| Shareholders' Equity | |||
| Total Equity | 65 | 65 | 15 |
| Share Capital | 55 | 55 | 28 |
| Reserves & Surplus | 10 | 9 | -12 |
Screen GENPHARMA income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 33 | 13 | 15 | 9 | 7 | 6 | 11 | 7 | 8 | 6 | 6 |
| Expenses | 33 | 11 | 15 | 8 | 6 | 5 | 10 | 6 | 8 | 6 | 6 |
| EBITDA | 0 | 2 | 0 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit % | -1.00% | 8.00% | -7.00% | 9.00% | 2.00% | 4.00% | 0.00% | 0.00% | -1.00% | 0.00% | 3.00% |
| Depreciation | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | -1 |
| Net Profit | -1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| EPS | -0.02 | 0.02 | -0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.04 |
Genpharmasec Cash Flow Screener - Liquidity Fundamentals
Screen GENPHARMA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March |
|---|---|---|---|
| Operating Activities | 3 | -3 | -3 |
| Investing Activities | -15 | -28 | 0 |
| Financing Activities | -1 | 48 | 3 |
| Net Cash Flow | -14 | 17 | 0 |
Screen GENPHARMA shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Feb | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 29.98% | 29.98% | 29.98% | 29.98% | 29.98% | 29.98% | 29.98% | 29.98% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 59.94% | 60.03% | 60.19% | 52.78% | 56.17% | 61.26% | 59.55% | 59.62% |
| Other Holding | 10.08% | 9.99% | 9.83% | 17.24% | 13.84% | 8.76% | 10.47% | 10.40% |
| Shareholder Count | 109,080 | 107,602 | 105,804 | 105,693 | 108,137 | 108,220 | 105,838 | 109,206 |
Genpharmasec Dividend Screener - Share Yield Analysis
Screen GENPHARMA dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Genpharmasec Index Membership - Market Screener Classification
Screen GENPHARMA by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Genpharmasec Market Events Screener - Corporate Actions
Screen GENPHARMA market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 1.04% | ||
| Change Of Name | NA | 0.00% | ||
| 2025-11-06 | 2025-11-06 | Quarterly Result Announcement | NA | -11.30% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | 0.00% |
| 2025-05-21 | 2025-05-21 | Quarterly Result Announcement | NA | 9.27% |
| 2025-02-10 | 2025-02-10 | Quarterly Result Announcement | NA | -11.46% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | -6.05% |
| 2024-07-23 | 2024-07-23 | Annual General Meeting | NA | 10.55% |
| 2024-01-09 | 2024-01-09 | Rights | 1:1 | 82.23% |
Genpharmasec Competitors Screener - Peer Comparison
Screen GENPHARMA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Redington | 21,526 | 11.29 | 99,562 | 11.11% | 1,821 | 48.15 |
| Elitecon International | 16,485 | 70.49 | 551 | 55040.00% | 70 | 42.47 |
| MMTC | 8,583 | 38.43 | 263 | 28.63% | 87 | 45.71 |
| BN Agrochem | 3,911 | 54.91 | 367 | 5071.83% | 20 | 60.12 |
| MSTC | 3,453 | 8.07 | 388 | -25.38% | 407 | 52.62 |
| Ravindra Energy | 2,951 | 43.40 | 262 | 79.10% | 23 | 56.53 |
| TCC Concept | 2,090 | 43.19 | 90 | 14.72% | 42 | 40.94 |
| Vintage Coffee & Beverages | 2,077 | 37.43 | 313 | 136.92% | 40 | 48.45 |
| Creative Newtech | 1,110 | 18.52 | 1,802 | 3.48% | 53 | 56.44 |
| Polo Queen Industrial And Fintech | 1,108 | 407.75 | 81 | 15.16% | 3 | 45.42 |
Genpharmasec Company Announcements - News Screener
Screen GENPHARMA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-11-11 | Submission Of Clear Copy Of Financial Results For The Quarter And Half Year Ended September 30 2025. | View |
| 2025-11-08 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-06 | Statement Of Deviation Or Variation In The Use Of Proceeds Of Rights Issue For The Quarter Ended 30Th September 2025. | View |
| 2025-11-06 | Unaudited Standalone & Consolidated Financial Results Of The Company For The Quarter & Half Year Ended 30Th September 2025. | View |
| 2025-11-06 | Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Thursday November 06 2025. | View |
| 2025-10-27 | Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday 06Th November 2025. | View |
| 2025-10-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-30 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-29 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-24 | Closure of Trading Window | View |
| 2025-09-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-05 | Reg. 34 (1) Annual Report. | View |
| 2025-09-05 | Notice Of 33Rd Annual General Meeting Of The Company To Be Held On September 29 2025. | View |
| 2025-09-02 | Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s | View |
| 2025-09-02 | Intimation Of Book Closure For Annual General Meeting | View |
| 2025-09-02 | Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Tuesday 02Nd September 2025. | View |
| 2025-08-28 | Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Tuesday 02Nd September 2025. | View |
| 2025-08-08 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-07 | Statement Of Deviation Or Variation In The Use Of Proceeds Of Rights Issue For The Quarter Ended 30Th June 2025. | View |
| 2025-08-07 | Unaudited Standalone & Consolidated Financial Results Of The Company For The Quarter Ended 30Th June 2025. | View |